Prenatal PPI, H2 Blocker Use Linked to Asthma Risk in Child

Share this content:
Prenatal PPI, H2 Blocker Use Linked to Asthma Risk in Child
Prenatal PPI, H2 Blocker Use Linked to Asthma Risk in Child

THURSDAY, Jan. 11, 2018 (HealthDay News) -- Prenatal, maternal, acid-suppressive drug use is associated with an increased risk of childhood asthma, according to a review published online Jan. 11 in Pediatrics.

Tianwen Lai, M.D., Ph.D., from Zhejiang University in China, and colleagues conducted a systematic literature review to identify eight population-based studies that assessed acid-suppressive drug use during pregnancy and the risk of childhood asthma in offspring.

In pooled analysis, the researchers found that acid-suppressive drug use in pregnancy was associated with an increased risk of asthma in childhood (relative risk, 1.45). Among proton pump inhibitor users, the overall risk of asthma in childhood increased (relative risk, 1.34). Similarly, the risk increased in histamine-2 receptor antagonist users (relative risk, 1.57).

"The evidence suggests that prenatal, maternal, acid-suppressive drug use is associated with an increased risk of childhood asthma," the authors write. "This information may help clinicians and parents to use caution when deciding whether to take acid-suppressing drugs during pregnancy because of the risk of asthma in offspring."

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

High Uptake, Acceptability of Rapid Fentanyl Test Strips

High Uptake, Acceptability of Rapid Fentanyl Test Strips

Significant link between receiving positive results, reporting positive change in overdose risk behavior

ACR: Walking Each Day May Cut Risk for TKA Over Five Years

ACR: Walking Each Day May Cut Risk for ...

Replacing 5 minutes of non-walking time with 5 minutes of moderate-to-vigorous walking beneficial

Short Respiratory Event Duration Ups Mortality Risk in OSA

Short Respiratory Event Duration Ups Mortality Risk in ...

Individuals with shortest-duration events had adjusted hazard ratio of 1.31 for all-cause mortality

is free, fast, and customized just for you!




Already a member?

Sign In Now »